Ashley Cimino‐Mathews

Also affiliated with Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Cancer Center, Johns Hopkins Hospital, Sidney Kimmel Comprehensive Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 21 papers. Top paper: “Association between pathologic response and survival after neoadjuvant therapy in lung cancer”.

Association between pathologic response and survival after neoadjuvant therapy in lung cancer

Nature Medicine(2023)10.1038/s41591-023-02660-6

N/A

4.9DataRank · unranked

167 citations

Ashley Cimino‐Mathews, Elizabeth D. Thompson, Mariano Provencio, Patrick M. Forde, Jonathan Spicer +19 more

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer

Science Translational Medicine(2023)10.1126/scitranslmed.add7872

N/A

0.790DataRank · unranked

25 citations

Tzu‐Ting Huang, Jayakumar R. Nair, Daniel An, Grant Zurcher, Erika J. Lampert +12 more

A Phase II Pilot Study of Anti‐ PD ‐ L1 , Durvalumab, and a PARP Inhibitor, Olaparib in Patients With Metastatic Triple‐Negative Breast Cancer With or Without Germline BRCA Mutation

Cancer Medicine(2025)10.1002/cam4.71220

N/A

0.104DataRank · unranked

1 citations

Ashley Cimino‐Mathews, Stanley Lipkowitz, Min-Jung Lee, Jayakumar R. Nair, B. Brooke Solarz +9 more

Human epidermal growth factor 2 (HER2) in early stage uterine serous carcinoma: A multi-institutional cohort study

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.07.016

N/A

0DataRank · unranked

86 citations

Omar Najjar, Shari Damast, Adriana Blakaj, Joan Tymon‐Rosario, Maryam Shahi +10 more

Digital Pathology Analysis Quantifies Spatial Heterogeneity of CD3, CD4, CD8, CD20, and FoxP3 Immune Markers in Triple-Negative Breast Cancer

Frontiers in Physiology(2020)10.3389/fphys.2020.583333

N/A

0DataRank · unranked

79 citations

Chang Gong, Jeremias Sulam, Elana J. Fertig, Alexander S. Szalay, Elizabeth M. Jaffee +5 more

Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000516

N/A

0DataRank · unranked

27 citations

Ashley Cimino‐Mathews, Joo Sang Lee, Jayakumar R. Nair, Min-Jung Lee, Akira Yuno +5 more

Human epidermal growth factor 2 (HER2) in early stage uterine serous carcinoma: A multi-institutional cohort.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6084

N/A

0DataRank · unranked

1 citations

Omar Najjar, Molly Klein, Maryam Shahi, Michelle Dolan, Ashley Cimino‐Mathews +9 more

Clinical importance of high-mannose, fucosylated, and complex N-glycans in breast cancer metastasis

JCI Insight(2021)10.1172/jci.insight.146945

N/A

0DataRank · unranked

103 citations

Oluwatobi Adelaja, Benjamin Balluff, Vinay Ayyappan, Caitlin M. Tressler, Nicole M. Jenkinson +8 more

Phase I Study of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors (ETCTN-9844)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-5017

N/A

0DataRank · unranked

35 citations

Christine I. Rafie, Chenguang Wang, David Lim, Adam Brufsky, Patricia LoRusso +16 more

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA-mutant ovarian cancer

medRxiv(2022)10.1101/2022.12.02.22283037

N/A

0DataRank · unranked

2 citations

Tzu‐Ting Huang, Jayakumar R. Nair, Daniel An, Grant Zurcher, Erika J. Lampert +12 more

Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0056

N/A

0DataRank · unranked

224 citations

Alexandra S. Zimmer, Michelle R. Padget, Ashley Cimino‐Mathews, Jayakumar R. Nair, Yingmiao Liu +13 more

Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

npj Breast Cancer(2020)10.1038/s41523-020-0154-2

N/A

0DataRank · unranked

168 citations

Elisabeth Specht Stovgaard, Eva Balslev, Jeppe Thagaard, Weijie Chen, Sarah Dudgeon +95 more

Spatial and Compositional Biomarkers in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.18.572234

N/A

0DataRank · unranked

10 citations

Ravi Varadhan, Ashley Cimino‐Mathews, Leisha A. Emens, Cesar A. Santa‐Maria, Aleksander S. Popel +1 more

Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial

Nature Cancer(2024)10.1038/s43018-024-00729-w

N/A

0DataRank · unranked

47 citations

Won Jin Ho, Ludmila Danilova, Joseph A. Tandurella, James M. Leatherman, Christine I. Rafie +22 more

Spatial Architecture of Single-Cell and Vasculature in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast Cancer

Modern Pathology(2024)10.1016/j.modpat.2024.100652

N/A

0DataRank · unranked

14 citations

Ravi Varadhan, Ashley Cimino‐Mathews, Leisha A. Emens, Cesar A. Santa‐Maria, Aleksander S. Popel +1 more

Mapping the breast tumor microenvironment: proximity analysis reveals spatial relationships between macrophage subtypes and metastasis-initiating cancer cells

Oncogene(2024)10.1038/s41388-024-03127-9

N/A

0DataRank · unranked

11 citations

Atul Deshpande, Jae W. Lee, Yeonju Cho, Sarah M. Shin, Erin M. Coyne +7 more

Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situ

Breast Cancer Research(2024)10.1186/s13058-024-01927-1

N/A

0DataRank · unranked

4 citations

Soonweng Cho, Bradley M. Downs, Michael Considine, Brittany Avin-McKelvey, Yongchun Wang +15 more

Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situ

UNC Libraries(2024)10.17615/efew-6r43

N/A

0DataRank · unranked

0 citations

Katherine A. Hoadley, Yongchun Wang, Wendy Cozen, Leslie Cope, Soonweng Cho +15 more

Updated pan-tumor guidelines for neoadjuvant scoring of pathologic response: a joint SITC and INMC effort

Annals of Oncology(2025)10.1016/j.annonc.2025.10.018

N/A

0DataRank · unranked

8 citations

Richard A. Scolyer, Elizabeth M. Burton, Klaus J. Busam, Kuang Yu Chen, Ashley Cimino‐Mathews +18 more

A clinical study of tremelimumab, alone or in combination with olaparib, for recurrent epithelial ovarian cancer

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.01.015

N/A

0DataRank · unranked

1 citations

Neha Verma, Maureen Berg, Jeanne Harrison, Peng Huang, James M. Leatherman +11 more

Quantitative proteomic landscape of metaplastic breast carcinoma pathological subtypes and their relationship to triple-negative tumors

Nature Communications(2020)10.1038/s41467-020-15283-z

N/A

0DataRank · unranked

171 citations

Maria E. González, Felipe da Veiga Leprevost, Shilpa R. Tekula, Hui-Yin Chang, Marissa J. White +7 more